POST REMISSION SEQUENTIAL MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 Q-PCR AND MULTIPARAMETRIC FLOW CYTOMETRY PREDICTS RELAPSE AND MAY HELP TO ADDRESS THE RISK ADAPTED THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS

MALAGOLA, Michele;Skert, C.;Borlenghi, E.;Chiarini, M.;Giustini, V.;Comini, F.;Cattina, F.;Cancelli, V.;Cerqui, E.;Farina, M.;Pagani, C.;Passi, A.;Schieppati, F.;Ribolla, R.;Ruggeri, G.;CAIMI, Luigi;RUSSO, Domenico;Rossi, G.

2015-01-01